CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 98 target
Drug / intervention
High Flow Nasal Cannula or Low Flow Nasal Cannuladevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03168815
NCT03168815N/AActiveUpdate OverdueUpdated 13mo ago · Completion was 6mo ago
Enrollment Stalled

Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy: A Randomized Controlled Trial

Mount Sinai Hospital, Canada·interventional·Posted May 30, 2017·Updated May 9, 2025

In Brief

A clinical study evaluating High Flow Nasal Cannula or Low Flow Nasal Cannula for Immunocompromised and 4 related conditions. Active but no longer recruiting, targeting 98 participants across 1 site.

Signals

Enrollment appears stalled

Detailed Summary

Pneumonia is a lung infection. Fiberoptic bronchoscopy is a test to diagnose the type of lung infection. While this procedure is being performed, a small amount of oxygen is delivered into the nose (low flow nasal cannula). Occasionally during this procedure, the blood oxygen of the patient may drop and an intervention such as increasing the oxygen flow, or placing the patient on a breathing machine is required. An alternative device called 'Optiflow' can provide high flow oxygen through nasal cannula, and is comfortable for patients. If Optiflow is used during bronchoscopy, it may prevent the blood oxygen from dropping.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada

Timeline

N/AActiveOverdue
201820192020202120222023202420252026
First PostedMay 30, 2017
Enrollment StartJan 10, 2018
Primary CompletionDec 31, 2025
TodayJul 2, 2026
Enrollment to primary: 8.0 yearsPosted 9.1 years ago

Interventions

High Flow Nasal Cannula or Low Flow Nasal Cannuladevice

HFNC vs LFNC